Neuropathic pain - page 3 Scientific Publications

Latest publication 05/01/2026

Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuro

In this study, we examined the effects of ibogaminalog (DM506), a nonhallucinogenic analog of ibogamine, in a mouse model of chemotherapy-induced...

Array
(
    [id_prestablog_news] => 2475
    [id_shop] => 1
    [date] => 2026-05-01 00:00:00
    [date_modification] => 2026-05-01 00:00:00
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [ishero] => 0
    [prim_key] => 4817
    [id_lang] => 1
    [title] => Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuro
    [paragraph] => Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in Mice | ACS Chemical Neuroscience
    [content] => 
Authors
Jason  Younkin, Eda  Koseli, Belle  Buzzi, Edward  Choi, Torin  Honaker, Randall L.  Davis, Dina  Manetti, Maria Novella  Romanelli, Aysel  Cetinkaya-Fisgin, Hugo R.  Arias, Ahmet  Hoke, Javier  Gonzalez-Maeso, M. Imad  Damaj

Lab
Journal
ACS Chemical Neuroscience
Abstract
In this study, we examined the effects of ibogaminalog (DM506), a nonhallucinogenic analog of ibogamine, in a mouse model of chemotherapy-induced peripheral neuropathy (CIPN) induced by paclitaxel. We also assessed the effects of tabernanthalog (TBG) and investigated the potential role of serotonin receptor subtype 2A (5-HT2AR) for both compounds. DM506 and TBG demonstrated antinociceptive activity in the CIPN model. DM506 produced a more prolonged effect, lasting between 10 and 14 days, with nociception reduction in mechanical (von Frey) and cold (acetone) hypersensitivity assays. These effects were observed in a dose- and time-dependent manner. Unlike some previous studies that reported effects lasting only hours, the effects we observed persisted for several days. Furthermore, neither compound produced long-lasting effects on locomotor activity, even at relatively high doses. The antinociceptive effects of both compounds in the CIPN mouse model were blocked by the 5-HT2AR selective antagonist volinanserin.In vitrostudies revealed that DM506 does not block cytokine/chemokine expression in microglial cells but partially protected dorsal root ganglion (DRG) neurons treated with paclitaxel in the 100–300 nM concentration range in a volinanserin-sensitive manner. We conclude that DM506 and TBG possess antinociceptive properties in mice via pathways involving 5-HT2AR activation. Although it is unlikely that this effect involves anti-inflammatory activity in microglia, partial neuroprotective activity in DRG neurons can be considered.
Keywords/Topics
ibogalogs; chronic pain; neuropathy; 5-HT2AR; mice; chemotherapy
    [meta_description] => 
    [meta_keywords] => https://pubs.acs.org/doi/abs/10.1021/acschemneuro.5c01002
    [meta_title] => 
    [link_rewrite] => Activity-of-Nonhallucinogenic-Ibogalogs-on-Chemotherapy-Induced-Peripheral-Neuropathic-Pain-in-Mice-|-ACS-Chemical-Neuroscience
    [actif_langue] => 1
    [read] => 0
    [count_comments] => 0
    [id] => 2475
    [categories] => Array
        (
            [29] => Array
                (
                    [id_prestablog_categorie] => 29
                    [title] => Neuropathic pain
                    [link_rewrite] => Neuropathic-pain
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in [...]
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [1206] => Array
                (
                    [name] => Modular holder cages for rats and mice
                    [description_short] => 
New ROBUST and modular cages to gently hold rodents (rats or mice) during nociceptive and analgesic tests including Hargreaves and Von Frey protocols: an innovative, solid, practical and user-friendly design by Bioseb.
                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/en/pain-mechanical-allodynia-hyperalgesia/1206-modular-holder-cages-for-rats-and-mice.html
                )

        )

)
1